Kawasaki Disease/COVID-19 Research Registry

The Association of Kawasaki Disease and COVID-19 with Cardiac Complications: A Focused Sub-study of the International Kawasaki Disease Registry (IKDR)

Protocol Description

Through this multi-center study, researchers are collecting data for analysis about pediatric patients with Kawasaki disease (KD) who have pediatric multisystem inflammatory syndrome (PMIS aka MIS-C) and/or confirmed or suspected COVID-19 infection. KD is a rare childhood illness that affects the blood vessels and can harm the coronary arteries, which carry blood to the heart muscle. Through this study, researchers hope to learn more about cardiac complications, including those associated with KD, in pediatric patients with COVID-19.

Eligibility Criteria

This study will include: 1) patients with confirmed or suspected COVID-19 infection for whom there has been a request for echocardiography or pediatric cardiology consultation; 2) patients with a confirmed or suspected diagnosis of KD, or KD shock syndrome; 3) patients with confirmed or suspected PMIS assumed to be associated with COVID-19.
Males and Females: All ages


There are no requirements for participants. Clinical data is extracted from the medical record for review and analysis.
Visits: None required
Duration: Not applicable

Status: Open to Enrollment

Source(s) of Support

International Kawasaki Disease Registry
The Hospital for Sick Children, Toronto, Ontario

Additional Information

Kawasaki Disease
Cardiology Research

Primary Investigator

Tyler Harris, MD

Contact Information

For more information about the study, please contact:
Cullen Wenzler, Clinical Research Coordinator